Literature DB >> 21438661

The effectiveness of 20 mev protons at nanosecond pulse lengths in producing chromosome aberrations in human-hamster hybrid cells.

T E Schmid1, G Dollinger, V Hable, C Greubel, O Zlobinskaya, D Michalski, S Auer, A A Friedl, E Schmid, M Molls, B Röper.   

Abstract

Laser accelerated radiotherapy is a potential cancer treatment with proton and carbon-ion beams that is currently under development. Ultra-fast high-energy laser pulses will accelerate ion beams that deliver their dose to a patient in a "pulsed mode" that is expected to differ from conventional irradiation by increasing the dose delivery rate to a tissue voxel by approximately 8 orders of magnitude. In two independently performed experiments at the ion microprobe SNAKE of the 14 MV Munich tandem accelerator, A(L) cells were exposed either to protons with 1-ns pulse durations or to protons applied over 150 ms in continuous irradiation mode. A slightly but consistently lower aberration yield was observed for the pulsed compared to the continuous mode of proton irradiation. This difference was not statistically significant when each aberration type was analyzed separately (P values between 0.61 and 0.85 in experiment I and P values between 0.32 and 0.64 in experiment II). However, excluding the total aberrations, which were not analyzed as independent radiation-induced effects, the mean ratio of the yields of dicentrics, centric rings and excess acentrics scored together showed (with 95% CI) a significant difference of 0.90 (0.81; 0.98) between the pulsed and the continuous irradiation modes. A similar tendency was also determined for the corresponding RBE values relative to 70 kV X rays. Since the different findings for the comparisons of individual chromosome aberration types and combined comparisons could be explained by different sample sizes with the consequence that the individual comparisons had less statistical power to identify a difference, it can be concluded that 20 MeV protons may be slightly less effective in the pulsed mode.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21438661     DOI: 10.1667/RR2465.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  14 in total

1.  Induction and repair of DNA double-strand breaks assessed by gamma-H2AX foci after irradiation with pulsed or continuous proton beams.

Authors:  O Zlobinskaya; G Dollinger; D Michalski; V Hable; C Greubel; G Du; G Multhoff; B Röper; M Molls; T E Schmid
Journal:  Radiat Environ Biophys       Date:  2012-01-07       Impact factor: 1.925

2.  New challenges in radiobiology research with microbeams.

Authors:  Marco Durante; Anna A Friedl
Journal:  Radiat Environ Biophys       Date:  2011-06-12       Impact factor: 1.925

3.  The influence of reference radiation photon energy on high-LET RBE: comparison of human peripheral lymphocytes and human-hamster hybrid AL cells.

Authors:  T E Schmid; C Greubel; G Dollinger; E Schmid
Journal:  Radiat Environ Biophys       Date:  2017-01-31       Impact factor: 1.925

Review 4.  Expanding the therapeutic index of radiation therapy by normal tissue protection.

Authors:  Pierre Montay-Gruel; Lydia Meziani; Chakradhar Yakkala; Marie-Catherine Vozenin
Journal:  Br J Radiol       Date:  2018-07-02       Impact factor: 3.039

5.  Biological effects in normal cells exposed to FLASH dose rate protons.

Authors:  Manuela Buonanno; Veljko Grilj; David J Brenner
Journal:  Radiother Oncol       Date:  2019-03-05       Impact factor: 6.280

Review 6.  Biological Benefits of Ultra-high Dose Rate FLASH Radiotherapy: Sleeping Beauty Awoken.

Authors:  M-C Vozenin; J H Hendry; C L Limoli
Journal:  Clin Oncol (R Coll Radiol)       Date:  2019-04-19       Impact factor: 4.126

7.  Model studies of the role of oxygen in the FLASH effect.

Authors:  Vincent Favaudon; Rudi Labarbe; Charles L Limoli
Journal:  Med Phys       Date:  2021-08-18       Impact factor: 4.071

8.  Survival of tumor cells after proton irradiation with ultra-high dose rates.

Authors:  Susanne Auer; Volker Hable; Christoph Greubel; Guido A Drexler; Thomas E Schmid; Claus Belka; Günther Dollinger; Anna A Friedl
Journal:  Radiat Oncol       Date:  2011-10-18       Impact factor: 3.481

9.  A Mechanistic DNA Repair and Survival Model (Medras): Applications to Intrinsic Radiosensitivity, Relative Biological Effectiveness and Dose-Rate.

Authors:  Stephen Joseph McMahon; Kevin M Prise
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

10.  Establishment of a small animal tumour model for in vivo studies with low energy laser accelerated particles.

Authors:  Kerstin Brüchner; Elke Beyreuther; Michael Baumann; Mechthild Krause; Melanie Oppelt; Jörg Pawelke
Journal:  Radiat Oncol       Date:  2014-02-18       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.